M.H.H. Kramer
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES (NCT03433248) | M.H.H. Kramer | 2017-11-09 |
| Renoprotective Effects of Dapagliflozin in Type 2 Diabetes (NCT02682563) | M.H.H. Kramer | 2016-02-01 |
Track M.H.H. Kramer automatically
Every clearance here is in the API, with alerts when new ones post.